Daewoong running into anti-cancer drug markets

Daewoong announced the anti-cancer drug business projects on Aug. 9, covering that until 2010 the company targeted to get 100 billion won of sales from the anti-cancer drug markets by realizing 3 subjects, namely, a differentiated product portfolio, a product design specialized for the domestic market and the company own or licensing-in product developments.

To achieve the 3 major subjects, ...